Kyungsangnam-do, South Korea

Jong Han Kim

This inventor holds 1 USPTO granted patent. Top assignee: Korea Research Institute of Bioscience and Biotechnology. Active years: 2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jong Han Kim. Retrieved from https://idiyas.com/inventor/jong-han-kim-r8t4uqc6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jong Han Kim in Cancer Research

Introduction

Jong Han Kim is a notable inventor based in Kyungsangnam-do, South Korea. He has made significant contributions to the field of cancer research through his innovative work on cinnamaldehyde derivatives. His research focuses on developing compounds that can inhibit tumor cell growth and regulate the cell cycle.

Latest Patents

One of Jong Han Kim's key patents is titled "Cinnamaldehyde derivatives inhibiting growth of tumor cell and regulating cell cycle, preparations and pharmaceutical compositions thereof." This invention relates to the development of cinnamaldehyde derivatives that effectively inhibit the growth of tumor cells and regulate the cell cycle. The compounds he has developed can be utilized as cell cycle regulators or cancer cell growth inhibitors. They possess the ability to hold cells in the G2/M stage of cell division, thereby demonstrating significant potential in cancer treatment. He holds 1 patent in this area.

Career Highlights

Jong Han Kim is affiliated with the Korea Research Institute of Bioscience and Biotechnology, where he conducts his research. His work has garnered attention for its potential applications in the pharmaceutical industry, particularly in developing new cancer therapies.

Collaborations

He has collaborated with esteemed colleagues, including Byoung-Mog Kwon and Kwang-Hee Son, to advance his research and explore new avenues in cancer treatment.

Conclusion

Jong Han Kim's innovative work in developing cinnamaldehyde derivatives showcases his commitment to advancing cancer research. His contributions have the potential to lead to significant breakthroughs in cancer treatment and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…